Genprex, Inc. reported that on August 15, 2025, its stockholders approved an amended equity incentive plan allowing for an increase of 6.5 million shares, which extends the plan's term to June 30, 2035. This event is significant from an investor’s perspective with a positive sentiment as it facilitates employee compensation and potential growth.